SCM LifeScience Co

SCM LifeScience Co Share Buybacks

The Share Buybacks of SCM LifeScience Co (298060.KQ) as of Nov 19, 2026 is 19.32 B KRW. In the previous year, Share Buybacks was 674.38 M KRW — a change of 2,764.29% (higher).

Share Buybacks

19.32 BKRW

YoY

2,764.29%

Last updated:

Share Buybacks of SCM LifeScience Co is 2023 19.32 B KRW. Share Buybacks of SCM LifeScience Co was 2022 674.38 M KRW. It decreases by 2,764.29% higher compared to the previous year.

The SCM LifeScience Co Share Buybacks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Buybacks
Date
Share Buybacks
Jan 1, 2018
44.07 B KRW
Jan 1, 2019
6.09 B KRW
Jan 1, 2020
32.26 B KRW
Jan 1, 2021
907.70 M KRW
Jan 1, 2022
674.38 M KRW
Jan 1, 2023
19.32 B KRW
The SCM LifeScience Co Share Buybacks history
YEARShare BuybacksYoY
19.32 BKRW+2,764.29%
674.38 MKRW-25.70%
907.70 MKRW-97.19%
32.26 BKRW+430.18%
6.09 BKRW-86.19%
44.07 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SCM LifeScience Co Stock analysis

What does SCM LifeScience Co do? SCM LifeScience Co Ltd is a biotechnology company headquartered in Incheon, South Korea. The company focuses on the development and production of cell therapy products, including adult stem cell therapies. It also engages in agency testing for cell production and quality assurance, as well as providing adult stem cell consulting services. Additionally, SCM LifeScience operates in the cosmetics and hair growth protein manufacturing sectors. The company has 55 full-time employees. SCM LifeScience completed its initial public offering (IPO) on June 17, 2020. Its stock is listed under the ticker 298060.KQ on the Korean stock exchange, with an ISIN code of KR7298060005. The company's website is http://www.scmlifescience.com/. SCM LifeScience operates within the healthcare sector, specifically within the biotechnology industry. It does not provide details on its founding year, specific product names, or financial figures beyond the IPO date and employee count. The company's activities span drug development for stem cell therapy, cell production testing, and manufacturing of related products. SCM LifeScience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCM LifeScience Co stock

Share Buybacks of SCM LifeScience Co is 19.32 B KRW in 2023.

Share Buybacks of SCM LifeScience Co changed from 674.38 M KRW to 19.32 B KRW, representing a 2,764.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Share Buybacks SCM LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's SCM LifeScience Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — SCM LifeScience Co

All Key Metrics — SCM LifeScience Co